6505--Notice of Intent to Sole Source Procurement - Flyrcado (F18 Flurpiridaz) Injection
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 17, has awarded a firm-fixed-price contract to Medi-Physics, Inc. (doing business as GE Healthcare) for the procurement of Flyrcado™ (flurpiridaz F-18) Injection. This sole source award, with an estimated total value of $1,288,946.25, covers five one-year ordering periods from March 2, 2026, to March 1, 2031.
Scope of Work
The contract is for the supply of Flyrcado™ (flurpiridaz F-18) Injection, a radioactive diagnostic agent used for Positron Emission Tomography (PET) myocardial perfusion imaging (MPI). This imaging is crucial for evaluating myocardial ischemia and infarction in patients with known or suspected coronary artery disease (CAD). The estimated annual quantity is 675 mCi.
Contract Details
- Awardee: Medi-Physics, Inc. (doing business as GE Healthcare)
- Contract Type: Firm-fixed-price
- Award Number: 36C25726D0056
- Award Date: March 10, 2026
- Estimated Total Value: $1,288,946.25
- Period of Performance: Five (5) one-year ordering periods, from March 2, 2026, to March 1, 2031
- Set-Aside: Sole Source (Only One Responsible Source)
- Product Service Code (PSC): 6505 (Drugs And Biologicals)
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
Justification & Procurement
This procurement was justified as a sole source action under 41 U.S.C. §3304(a)(1) (FAR 6.302-1), citing that Medi-Physics, Inc. is the only responsible source. Market research conducted from August 29, 2025, through January 14, 2026, confirmed that GE Healthcare is the sole manufacturer of Flyrcado™, and no other sources, including small businesses or mandatory sources, could provide the required radiopharmaceutical. A notice of intent was posted to SAM Contract Opportunities on January 6, 2026, and no responses were received.
Point of Contact
Vance Farrell, Contract Specialist, vance.farrell@va.gov.